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HRB formed by the 
amalgamation of  
Medico-Social Research 
Board and the Medical 
Research Council  
of Ireland
National Drug Treatment  
Reporting System 
established
First HRB corporate plan 
identifies R&D for health, 
increasing post grad 
training, promoting college 
/hospital/industry linkage 
and developing private  




patient Reporting System 
and Three County Register
Move to external peer  
review process
Traveller studies published 
showing 
• 50% travellers housed 
compared to 5% in 1960.
• 50% live in Cork, Galway,  
Limerick and Dublin
• Fertility and mortality rates  
are x2 of settled population
Peter Humphries, TCD, 
discovers gene causing a 
form of inherited blindness
HRB scales up awareness 
about EU funding
National Intellectual 
Disability Database set up
First assessment 
of health services 
research capability 
shows that while it is 
underdeveloped, Ireland 
has good strengths on 
which HSR capacity can 
be built if funding is  
provided and people 
collaborate
Kathleen Quane and 
Tommie McCarthy, UCC, 
identify molecular defect 
responsible for central 
core disease
Dermot Walsh, HRB, 
identifies a specific 
gene contributing to 
schizophrenia risk
Major Irish / US study on 
alcohol dependence gets 
underway using data from 






IR£2.3 - IR£1.6m                IR£1.7 - IR£3.5m                IR£3.5m - €13.2m                              €22.8m - €43.2m                  €53m - €39.5m                     €37.1m - €43.8m
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A look back over 30 years of growth and success highlights 
Government publish first 
health research strategy 
Making knowledge work  
for health 
Government matched 
funding agreement  
with Wellcome Trust 
secures €6million for 
biomedical research 
Launched programme 
grants worth €12 million 




HRB becomes Irish Focal  
point for the European  
Monitoring Centre on 
Drugs and Drug Addiction  
HRB Drugs library opens
National Physical and  
Sensory Disability Database 
established
HRB Investment programme 
in health and wealth secures 
€50m in capital funding for 
next 5 years
Started Clinician Scientist 
funding
Partnership with Wellcome 
to set up Clinical Research 
Facilities in Ireland
National Drug-Related Deaths 
Index established
HRB funds ICORG (now Cancer 
Trials Ireland) to co-ordinate 
cancer clinical trials on island 
of Ireland
Mant report on Primary Care  
R & D in Ireland, points to need 
for HRB Centre for Primary 
Care Research
Peadar Kirke, HRB, and 
team from Trinity and NIH 
in United States, identify 
that up to 70% of Neural 
Tube Defects, such as Spina 
Bifida, could be prevented 
by taking folic acid
First Picture of Health 
publication captures outcomes 
of our funded research in 
layman’s terms
HRB’s NIDD cited in budget 
speech supporting case for 
securing €400m for  
disability services
3D imaging equipment 
provided to 7 hospitals to 
support perinatal research  
and improve outcomes for 
mums and babies
First gene for Motor Neuron 
Disease identified by Orla 
Hardiman and her international 
team shedding light on root 
cause of disease
Bernard Mahon’s work at 
Maynooth University shows that 
a naturally occurring antibiotic 
in the lungs can disrupt cell 
walls of bacteria like MRSA
1997-2001 2002-2006
Budget:  
IR£2.3 - IR£1.6m                IR£1.7 - IR£3.5m                IR£3.5m - €13.2m                              €22.8m - €43.2m                  €53m - €39.5m                     €37.1m - €43.8m
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HRB Centres in diet and 
health and primary care 
research established. These 
go on to influence sugar tax 
and a range of new clinical 
guidelines for GPs
€19 million for new PhD 
programmes to advance 
skills base in cancer biology, 
immunology, diagnostics and 
health services research (now 
SPHeRE Programme)
HRB Making an impact report 
led to payback framework  
to measure the impact of 
funded research
HRB publishes Review of 
Population Health Services 
and Health Services Research 
in Ireland
New strategic business plan 
shifts focus of funding to 
patient-oriented, population 
health and health services 
research
Transformed infrastructure 
for clinical research in Ireland 
opening 3 clinical research 
facilities, creating 4 new  
clinical trial networks, 
establishing a Trial 
Methodology Research 
Network and a hub to 
co-ordinate trials, HRB CRCI
Increased funding support for  
population health and health  
services research
Progress to consolidate all 
health information systems 
on one platform to better 
support service planning 
HRB Evidence Centre 
established and delivering 
for key policy areas such as 
alcohol, suicide and water 
fluoridation
New HRB strategy 2016 – 2020
Public and Patient Involvement 
takes centre stage
New online grant  
management system 
revolutionises approach  
to managing grants across  
entire lifecycle
First report on drug-related 
deaths shows poisoning as 
main cause of death
Commercial development  
of a diagnostic tool for 
automated cancer screening 
on foot of HRB funding to  
Paul Whelan in DCU
New statistical model 
developed to help hospitals 
manage blood stocks by 
Anthony Staines in DCU
Mary Fitzsimons, Beaumont 
Hospital, develops epilepsy 
patient record which is now 
being used as a model for 
chronic disease management 
Luke O Neill in TCD identifies 
master switch which turns the 
immune system on in response 
to harmful bacteria
HRB report highlights social 
consequences of alcohol use
Research at a population 
level, as fostered by Hannah 
McGee’s HesSSOP study 
and SLAN survey 2007, 
helped increase policymaker 
appreciation of the value of 
robust population data and led 
to funding of TILDA and GUI
Denis O’Mahony, UCC, 
develops STOPP START 
pharmacy management tool 
that could save health services 
€180 million per year
HRB Alcohol Survey reveals 
1.35million Irish people 
drinking to harmful levels
Report confirms that there 
is no definitive evidence that 
community fluoridation of 
water supply has negative 
health effects
Steve Thomas, TCD, produces 
Resilience Study which 
provides a forensic analysis of 
how the health system coped 
with decreasing of resources
Fergal Malone, RCSI, and 
Perinatal Ireland team  
generate new guidelines  
for monitoring babies in  
the womb
Declan Soden, UCC, develops 
new tool for zapping 
inoperable cancer tumours
Kathleen Bennett, RCSI, 
discovers Aspirin may have 
important role in reducing 
breast cancer
Mary Cannon, RCSI, increases 
national focus on youth  
mental health with some  
stark findings in the area
Tailor X trial brings 
personalised medicine  
into breast cancer care
2007-2011 2012-2016
Budget:  
IR£2.3 - IR£1.6m                IR£1.7 - IR£3.5m                IR£3.5m - €13.2m                              €22.8m - €43.2m                  €53m - €39.5m                     €37.1m - €43.8m
#HRB30
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During 2016, the HRB launched a new 
organisational strategy 2016–2020, 
Research. Evidence. Action. It charts  
a clear, ambitious course over this  
five-year period. A rebrand in response 
to a stakeholder consultation also 
reflected a new energy and direction  
for the organisation. 
This internal shift in momentum was mirrored 
externally as we continued to grow the 
reputation of the HRB, both nationally and 
internationally. It was particularly encouraging 
to see the use of HRB evidence to inform 
decision-making in policy and practice in 
relation to the introduction of a new Food 
Pyramid and the Public Health (Alcohol) Bill. 
Our participation on national and European 
boards has also helped increase recognition of 
the contribution that the HRB is making. This is 
particularly evident in key areas including data 
linkage, open science, clinical effectiveness 
and research integrity.
During the first year of the new strategy there 
was solid progress against HRB objectives. 
Some key achievements included: 
• Launching a selection of new awards 
aligned to our strategic priorities, such as:
 > Definitive Intervention and   
 Feasibility Awards to support   
 healthcare interventions. 
 > Applied Partnership Awards to bring  
 researchers and knowledge users  
 together to focus on research   
 questions highlighted in the Irish  
 health and social care system. 
 > Investigator Led Projects to create  
 new knowledge to address major health  
 challenges in society and have an  
 impact on future healthcare.
 > HRB Collaboration in Ireland for  
 Clinical Effectiveness Reviews to  
 conduct evidence reviews and provide  
 scientific support for the development  
 of clinical practice guidelines for  
 the National Clinical Effectiveness  
 Committee. 
• Going live with the new online data 
collection system, LINK, which is an 
ambitious programme to synchronise  
our five national health information  
systems and receive data from service 
providers online. 
• Publishing the report Proposals for an 
Enabling Data Environment for Health and 
Related Research in Ireland, which maps a 
course for the safe access, storage, sharing 
and linkage of health-related data.
• Producing five evidence reviews and two 
evidence briefings for the Department  
of Health.
• Creating new supports and mechanisms to 
encourage Public and Patient Involvement 
(PPI) in research. 
• Expanding the scope of the National 
Drug-Related Deaths Index to include 
the collection of data on all suicides. This 
Chairman and  






Research. Evidence. Action 5
builds on the HRB’s success in relation 
to the collection of road safety data and 
deaths due to fire. 
• Introducing a staff and organisational 
development programme.
• Hosting a conference to mark 30 years of 
HRB output and impacts.
• Exceeding Horizon 2020 health targets in 
terms of securing funding.
• Publishing a report on Alcohol in  
Ireland: consumption, harm, cost and  
policy response. 
Through our funding mechanisms, the HRB:
• Invested €58.6 million in 111 awards across 
30 host institutions.
• Supported 663 research jobs. 
• Helped Irish researchers leverage  
€8.9 million from Horizon 2020. 
• Involved 14,523 patients in 344 clinical 
trials at HRB Clinical Research Facilities.
• Enabled 2,403 cancer patients to enrol  
in clinical trials conducted by Cancer  
Trials Ireland. 
• Appointed four new Research Leaders 
in the areas of suicide prevention, safe 
prescribing, dementia care and team 
leadership in the health services.
Additional examples and case studies which 
demonstrate what was achieved during the 
year are highlighted throughout this report.
The advances made in 2016 put the HRB in a 
strong position to deliver on the ambitious 
targets presented in the new HRB Strategy 
2016–2020, Research. Evidence. Action. This 
was only possible through the dedication and 
drive of HRB staff and commitment of our 
Board members. 
Looking to the future, it is clear that this 
strategy and the outcomes it delivers will 
position research at the heart of the health 
system, leverage more from the investments 
made in health, and ensure that evidence is 
used to inform decision-making about policy 
and practice. 
Dr Declan Bedford Dr Graham Love
Chairman   Chief Executive 
 
€58.6m
invested in 111 awards  
across 30 host  
institutions.





HRB Launch Strategy 
2016–2020
Research. Evidence. Action.  
The HRB will invest €250 million to 
drive innovation in clinical practice, 
health service design and delivery, 
and embed research at  
the core of the Irish  
health system.
€4.5m  
for seven dementia  
research projects  
with the Atlantic  
Philanthropies.
Professor Eamon O’Shea, NUI 
Galway, received € 1.6m to become 
a HRB Research Leader in Dementia.
Open Science  
and Ireland
Organisers and  
keynote speakers at 
at Open Science and 
Ireland event.
TB breakthrough opens way for 
immunotherapy treatment as 
HRB-funded researchers at  
St. James’s Hospital and Trinity 
College Dublin discover new 
avenues to treat multi-drug-
resistant tuberculosis.
Dr Laura Gleeson, 
TCD and St. James’s Hospital
€5.7m  
For four new HRB Research Leaders 
awards in the areas of suicide 
prevention, safe prescribing, 
dementia care and team leadership 
in health services.
Launched new  
Applied Partnership  
Award Scheme 
Researchers and knowledge users must actively 
engage throughout the research cycle, starting 
with identifying the research question and then 
using the research findings to influence policy 
and/or practice.
Research. Evidence. Action 7
Research involving a team of Irish, 
American and Canadian researchers 
reveals that the immune system could 
be responsible for as much as 40% of 
our body’s ability to regulate weight.
Brendan Quinn, fitness instructor, 
who participated in the 





Minister of State with special 
responsibility for Disabilities, 
Finian McGrath, T.D.  
presents David McKenna 
with his prize for winning 
the competition to design 
the cover of the National 
Intellectual Disability 
Database (NIDD) report.  
His painting was selected 
from more than 250  
entries nationwide.
Youth colouring book takes a ‘journey 
through the brain’ to illustrate the 
connections between the brain, 
emotional and mental health and  
overall well-being.  
HRB publishes annual report and census data 
from Irish psychiatric units and hospitals.
Research. Evidence. Action.
HRB Statistics Series 29 
Activities of Irish Psychiatric Units 
and Hospitals 2015 Main Findings
Antoinette Daly and Sarah Craig
Research. Evidence. Action.
HRB Statistics Series 31
Annual Report of the  
National Physical and Sensory  
Disability Database Committee 2015
Sarah Hourigan, Anne Doyle and Anne Marie Carew



























HRB report on Alcohol 
in Ireland: consumption, 
harm, cost and  
policy response
Dr Deirdre Mongan,  
HRB, lead author
HRB publishes Research Careers 
Framework and Action Plan, 
setting out the actions to develop a 
skilled workforce engaged in health 
research in Ireland.
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Good drugs for bad 
bugs – Research by 
Professor James 
O’Gara at NUI Galway 
shows that penicillin 
weakens MRSA 
bacteria, making them 
more vulnerable to 
other antibiotics and 
the immune system.
 
Funding eligibility to be linked to 
gender equality accreditation
The HRB and other Irish research funding 
agencies will require higher education 
institutions to have Athena SWAN gender 
equality accreditation in place by 2019 in 
order to remain eligible for research funding.
The MAMMI Study – Cecily Begley and 
Deirdre Daly, TCD – revealed a litany of 
hidden health problems affecting every 
aspect of mothers’ lives, including mental, 
physical and sexual health.
€73 billion  
HRB-funded research 
estimates that premature 
cancer deaths will cost the 
Irish economy €73 billion 
over the next 20 years.
HRB invests €2.5 million in 
the Collaboration in Ireland 
for Clinical Effectiveness 
Reviews (HRB-CICER) 
initiative, a multidisciplinary 
team supported by experts 
in the Health Information and 
Quality Authority (HIQA) and 
the HRB Centre for Primary 
Care Research at RCSI 
(Royal College of Surgeons in 
Ireland) to assist the Health 
Service Executive’s (HSE) 
clinical guideline development 
groups and ensure that 
evidence underpins patient 
care and safety.
Drug-related deaths figures – 
62% increase over 10 years
Almost two people died each day in Ireland 
during 2014 as a result of poisoning, trauma 
or medical causes linked to drug use. 
Research. Evidence. Action 9





to public and patient 






compares the Irish 
drug situation with 
the rest of Europe
HRB-funded researchers’ 
success at the Irish 
Healthcare Awards
Sean Kirwan, UCD, received a 
special commendation for his 
series of patient information videos 
produced with his HRB Knowledge 
Exchange and Dissemination Award.
 
Professor Fidelma Dunne,  
HRB-funded Atlantic-DIP  
project (Diabetes In Pregnancy), 
overall winner at 2016 Irish 
Healthcare Awards.
Screening tool to reduce adverse 
drug reactions among elderly 
patients and reduce exchequer  
medication costs.
€40m  
Irish health researchers secure  
over €40 million from the  
EU for research and  
innovation projects.
A new Irish study, using data 
from the HRB’s National Alcohol 
Diary Survey 2013, shows that 
minimum unit pricing for alcohol 
will affect 14% of drinkers.
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Key deliverables  
in line with  
HRB strategy  
2016 - 2020
1
Research. Evidence. Action 11
The HRB Strategy 2016–2020 charts a clear 
course for what the organisation will do over 
the next five years.
This annual report highlights key achievements 
made during 2016 in line with the strategy 
objectives, and it showcases some examples 
of significant outcomes and success.
Focus areas 
As the lead national agency for health research 
in Ireland, we have a responsibility to invest in 
the future as well as to meet the needs of today’s 
health system. Great ideas are the basis for 
many advances in healthcare. We have defined 
the following three distinct but complementary 
areas of focus that we consider to be the most 
appropriate to lead the HRB and its community 
over the period 2016–2020 and beyond:
• Address major health challenges.
• Support healthcare interventions.
• Address the research needs of the 
Irish health and social care system.
Enabling themes
Progress in the three focus areas will be 
enabled and maximised by policies and 
actions that affect all three:
• Supporting the exceptional researchers and 
leaders we need to undertake high-quality 
health research and generate evidence.
• Building a strong enabling environment for 
health research in Ireland and ensuring that 
we understand the outcomes and demonstrate 
the impacts of our investments.
• Ensuring that our policies and governance 























Address the research 
needs of the Irish health 











Figure 1.  
Core elements of HRB strategy 2016-2020
Our three focus areas and enablers are complementary and interdependent, 
and we will pursue them simultaneously throughout the period of the strategy.
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2016 Objectives: 
• Support high quality, investigator-led, 
internationally competitive research.
• Develop and implement co-funding 
opportunities with international agencies 
and institutions.
Key items delivered in 2016
• Thirty-one awards, worth €18.3 million, 
supported this focus area. 
• Eleven of these awards, worth €13.3 million, 
involved international collaboration.
• Launched a new grant scheme called 
Investigator-Led Projects (ILP). This 
replaces the Health Research Award 
scheme. One hundred and fifty applications 
received and under review.
• Funded seven additional Health Research 
Awards (project grants) worth €2.3 million.
 > US-Ireland Research and Development  
 Partnership scheme. Funded two  
 awards worth €6.8 million (HRB 
 contribution of €0.7 million).
 > Medical Research Charities Group.  
 Made 13 awards worth €2.5 million  
 (HRB contribution of €1.5 million).
 > National Children’s Hospital Foundation  
 (NCHF). Launched new funding   
 instrument for paediatric research at  
 the National Children’s Hospital (€1  
 million investment by NCHF).
• Reconfigured the National Institutes of 
Health (NIH) partnership with Science 
Foundation Ireland and the Public Health 
Agency’s Health and Social Care R&D 
Division (HSC R&D) in Northern Ireland. 
This will broaden health research areas 
covered, make the programme more 
attractive to researchers and simplify 
administration (expect an increase in 
applications/awards to follow from  
2017 onwards).
Focus area 1  
 
Address major  
health challenges
€18.3m
Made thirty-one awards  
worth €18.3 million.
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The HRB has a long track 
record of working with Irish 
and international funding 
organisations, including  
Wellcome (formerly the 
Wellcome Trust) and Science 
Foundation Ireland (SFI), 
to name just two of many. 
Since 2010, the HRB, SFI and 
Wellcome have formed a 
strategic partnership that 
gives Irish researchers access 
to Wellcome funding schemes.
In recent years, Wellcome 
has been one of the largest 
international supporters 
of Irish research. Since 
2005, it has awarded 249 
grants to Republic of Ireland 
institutions. These awards, 
made in partnership with 
the HRB and SFI, had a total 
Sterling value of £44 million. 
In 2016 alone, the HRB,  
with Wellcome and SFI, 
co-funded health research 
awards worth €11.3 million. 
Some of these included:
Wellcome Institutional 
Strategic Support Fund. 
For the first time, two Irish 
universities were successful 
in this scheme. Trinity College 
Dublin (TCD) and University 
College Dublin (UCD) have 
each secured €1.1 million.
In TCD, the award will:
• support newly independent 
investigators
• support an international 
collaboration programme
• further enhance public 
engagement activities. 
In UCD, the award will support:
• a scheme aimed at giving 
early-career medical 
doctors and veterinarians 
the opportunity to work in 
a research setting  
• a targeted scheme for  
mid-career researchers
• the creation of networks 
of excellence, supporting 
public engagement and 
collaborations with other 
researchers.
Investigator Award. Professor 
Luke O’Neill secured €2 
million in funding through  
this partnership to investigate 
new theories about how 
certain cells behave and  
cause inflammation, in 
the hope of finding new 
therapies to treat a range of 
inflammatory diseases.
Seed funding awards. Four 
Irish researchers secured 
€400,000 each to explore 
their own novel research 
ideas. Seed Awards help 
researchers develop novel 
ideas that will go on to 
form part of larger grant 
applications to Wellcome  
or elsewhere.
Case Study 1:  
SFI-HRB-Wellcome Biomedical Research Partnership
In 2016 alone, the HRB, 
with Wellcome and 
SFI, co-funded health 
research awards worth 
€11.3 million.
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The Investigator Led Projects 
(ILP) scheme was launched 
in 2016 and replaced the 
HRB’s Health Research Award 
(HRA) scheme. ILP awards are 
projects with a 24–48-month 
lifespan and have a maximum 
budget of €370,000. The HRB 
received 150 applications 
to the scheme in 2016. At 
the time of writing, these 
applications are under 
international peer review to 
select the best projects. The 
HRB will fund approximately 
30–35 of these awards in 2017. 
The scheme aims to support 
the creation of new knowledge 
to address the major health 
challenges in society and to 
have an impact on future 
healthcare. Projects must be 
in one of the following areas:
• Patient-oriented research
• Population health research
• Health services research.
They can address topics 
almost anywhere on the 
research spectrum, including 
how to maintain and promote 
health and well-being, how 
to prevent or treat illness, or 
how best to organise health 
systems. Projects must be 
cutting edge, add to the 
international knowledge base, 
and focus on important, timely 
research questions where the 
answers are of interest to an 
international audience.
The ILP scheme complements 
two other major project grant 
schemes in the HRB strategy 
2016–2020, namely the 
Applied Partnership Awards 
(APA) and the Definitive 
Interventions and Feasibility 
Awards (DIFA).  
In 2016, ongoing or previous 
Health Research Awards 
produced outstanding  
results which received 
significant media attention.  
These included:
• Professor Donal O’Shea’s 
(St Vincent’s University 
Hospital) discovery that 
the immune system plays 
a major role in regulating 
body weight and obesity.
• Professor James O’Gara’s 
(NUI Galway) discovery that 
penicillin weakens MRSA 
bacteria and leaves them 
susceptible to other drugs 
and to the patient’s  
immune system.
• Professor Cecily Begley’s 
(TCD) results, which 
demonstrated high 
prevalence rates of hidden 
health problems facing 
mothers, including mental, 
physical and sexual health, 
through the Maternal 
Health and Maternal 
Morbidity in Ireland 
(MAMMI) study.  
Case Study 2:  
Investigator-Led Projects  
The scheme aims to 
support the creation 
of new knowledge 
to address the major 
health challenges in 
society and to have 
an impact on future 
healthcare.
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2016 Objectives: 
• Support the design, conduct and evaluation 
of intervention studies.
• Facilitate the coordination, enabling 
mechanisms and national/international 
collaborations that improve the volume, 
quality, relevance and impact of trials and 
intervention studies in Ireland.
Key items delivered in 2016
• Made five awards, worth €9.7 million,  
in this focus area. These included:
 > Cancer Trials Ireland who received two  
 awards with a combined value of €9  
 million to support a broad range  
 of investigator-led clinical trials in  
 Irish hospitals.
 > Two clinical intervention studies worth  
 €0.5 million in total, which were   
 funded through the HRB-Medical  
 Research Charities Group scheme.
• Launched the Health Research Board 
Clinical Research Coordination Ireland 
(HRB-CRCI). This will act as the national 
coordinating hub for all clinical trials  
in Ireland.
• Revised and launched the Definitive 
Interventions and Feasibility Awards (DIFA) 
scheme. This scheme supports intervention 
trials and feasibility studies in clinical and/
or population health research and/or 
health services research. The HRB received 
50 applications in round one. First awards 
will be announced in mid-2017. 
• Organised a review of the HRB Trials 
Methodology Research Network (HRB-
TMRN) and designed a proposal for  
next-phase funding. 
• Submitted business cases to the 
Department of Health for national 
membership in the Biobanking and 
Biomolecular Resources Research 
Infrastructure – European Research 
Infrastructure Consortium (BBMRI-ERIC) 
and the European Clinical Research 
Infrastructure Network – European 
Research Infrastructure Consortium 
(ECRIN-ERIC).





awarded to Cancer  
Trials Ireland
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Ireland’s clinical trials 
ecosystem received a major 
boost with the launch of 
HRB-CRCI in September 2016. 
This is the final part of a 10-
year, €100 million strategic 
investment by the HRB to 
develop Ireland’s capacity to 
conduct clinical trials to best 
international standards.  
A suite of earlier award 
schemes has provided 
researchers with the skills to 
conduct trials; the facilities 
in which to carry out those 
trials; and the specialist staff, 
peer networks and high-tech 
equipment required to support 
clinical trials.
As the national coordinating 
hub for all clinical trials in 
Ireland, HRB CRCI will add 
further value by: 
• acting as a single point  
of contact for anyone 
wishing to participate in 
national and international 
clinical trials
• assisting health 
professionals to get 
involved in clinical research
• guiding academics to 
develop research proposals 
that involve patients
• helping the life sciences 
industry deliver high-quality 
clinical research in Ireland
• helping patients to 
understand more about 
clinical research and  
how they can participate  
in trials.
Case Study 3:  
More Irish people will have access 
to multi-centre clinical trials
As the national 
coordinating hub for 
all clinical trials in 
Ireland, HRB-CRCI 
will add further value 
by assisting health 
professionals to get 
involved in clinical 
research.
Pictured at the launch of  
the HRB-CRCI were: Prof Joe 
Eustace, Chair and Director,  
HRB-CRCI, Dr Fionnuala Keane, 
Chief Operating Officer,  
HRB-CRCI, Dr Graham Love,  
Chief Executive, HRB, Marcella 
Corcoran Kennedy, TD, Minister  
of State for Health Promotion.
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Definitive interventions are 
large projects, typically of 
24–48 months’ duration, with 
budgets of up to €1 million 
each. They provide high-quality 
evidence on the effectiveness, 
cost and broad impact of a 
therapy or intervention  
under investigation.
Feasibility studies provide a 
pipeline of ideas and proofs-
of-concept for future definitive 
intervention studies.
Until recently, Ireland did not 
have the research ecosystem 
to support significant activity 
in this area. However, targeted 
HRB investments in clinical 
research facilities, clinical trials 
networks and other supports 
have changed that. 
Now, to augment these  
large-scale investments,  
the HRB will commit 
approximately €18 million 
over the course of 2016–2020 
to build research activity in 
Definitive Interventions and 
Feasibility Awards.
With almost 50 applications  
in its first round, DIFA 
has already generated 
considerable interest. The  
first awards are expected  
to be announced in 2017.  
The international review 
panels have commended  
the scientific excellence  
of applications. 
Case Study 4:  
€18 million for Definitive Interventions  
and Feasibility Awards (DIFA)
Feasibility studies 
provide a pipeline  
of ideas and 
proofs-of-concept  
for future definitive 
intervention studies.
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2016 Objectives: 
• Support research that addresses 
questions of national relevance for clinical 
and population health practice and for 
health services management, as well as 
translation of the research results into 
policy and/or practice. 
• Provide high-quality, timely and relevant 
data for policy, service planning and 
research through the HRB’s National Health 
Information Systems (NHIS). 
• Promote and support evidence synthesis 
and knowledge translation activities in 
order to help policy-makers, service 
planners and providers make evidence-
informed decisions.
Key items delivered in 2016
• Made twelve awards, worth €13.3 million, in 
this focus area. These included:
 > Awarded €10 million in funding over  
 five years to continue The Irish   
 Longitudinal Study on Ageing (TILDA).
 > Launched the first round of a new  
 Applied Partnership Programme, which  
 requires co-management of research  
 projects by academic and policy/ 
 health system Principle Investigators.  
 Made six awards with a combined  
 value of €1.3 million in this scheme  
 (HRB contribution €1.1 million, with  
 €0.2 million provided by health care  
 organisations).
 > Made two awards with a combined  
 valued of €540,00 with the Health  
 Services Executive and the Royal  
 College of Physicians of Ireland under  
 the Research Collaborative in Quality  
 and Patient Safety. 
 > Awarded €177,256 in funding for   
 a pilot project to evaluate the   
 implementation of the    
 recommendations from the  
 Taskforce on Staffing and Skill Mix  
 for Nursing in specialist medical  
 and surgical care settings in  
 acute hospitals. 
• Awarded 10 Cochrane fellowships  
worth €513,000. 
• Collaborated with 29 partners in a 
coordination and support action for 
the TO-REACH project (Transfer of 
Organisational innovations for Resilient, 
Effective, equitable, Accessible, sustainable 
and Comprehensive Health Services and 
Systems). The project is funded by a €2 
million Horizon 2020 award.  
• Worked with the Department of Health to 
launch a call, up to the value of €900,000, 
for a three-year research programme 
that will underpin the development and 
evaluation of safe nurse staffing policies 
aligned with the work of the Taskforce 
on Staffing and Skill Mix for Nursing in 
specialist medical and surgical care settings 
in acute hospitals.
• Published four National Health Information 
Systems (NHIS) Annual Reports. 
Focus area 3  
 
Address the research 
needs of the Irish health 
and social care system
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• Published four peer-reviewed articles 
based on NHIS data. 
• Introduced the new LINK online system to 
gather data from centres providing services 
that report to the National Drug Treatment 
Reporting System (NDTRS). 
• Extended the remit of the National Drug-
Related Deaths Index (NDRDI) to collect 
suicide data. 
• Completed five evidence reviews and  
two evidence briefings for the Department 
of Health. 
• Fulfilled the contractual commitments 
as the Irish Focal Point to the European 
Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA).
• Provided drug-related evidence to inform 
the development of the new National  
Drugs Strategy. 
• Published four issues of Drugnet Ireland. 
• Published Alcohol in Ireland: consumption, 
harm, cost and policy response.
Provided drug-related 
evidence to inform the 
development of the new 
National Drugs Strategy.
The HRB’s National 
Health Information 
Systems (NHIS) provide  
high-quality, timely  
and relevant data for 
policy, service planning 
and research.
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The working titles of HRB 
evidence reviews often speak 
for themselves in terms 
of the value that the HRB 
brings to evidence-informed 
policy-making in Ireland. Four 
examples from our 2016  
output include:
• Barriers and facilitators 
to successful hospital 
mergers: A systematic 
review
• Health workforce planning 
models, tools and 
processes in five countries: 
An evidence review
• Individualised budgeting 
for social care services for 
people with a disability: 
International approaches 
and evidence on financial 
sustainability
• Interventions that promote 
increased breastfeeding 
rates and breastfeeding 
duration among women:  
An umbrella review.
 
A HRB evidence review 
from 2015 titled Evidence 
review of the food contents 
on carbohydrate and fats 
shelves of the food pyramid 
contributed to the revised 
Food Pyramid that was 
published by the Department 
of Health in December 2016. 
Case Study 5:  
High-quality evidence for the Irish 
health and social care system
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In June 2016, the National Drug 
Treatment Reporting System 
(NDTRS) became the first HRB 
information system to go live 
on LINK. 
The LINK project will move all 
five HRB information systems 
onto a single common platform 
that will provide an integrated 
approach to health information 
management within the HRB. 
LINK brings internal and 
external benefits. It will:
• enhance compliance with 
data protection and data 
security requirements 
• improve data quality by 
allowing validation at the 
point of entry 
• rationalise the complex 
software support, 
maintenance and 
development of those  
five very different 
information systems.
For users of our information 
systems, the change will:
• remove the requirement for 
paper copy forms
• improve the quality of data 
to which they have access
• enable them to conduct 
analysis on their own data.
To date, 234 people from 
96 drug treatment service 
providers have been trained 
in how to use the new NDTRS. 
There are currently over 
40,000 treatment episode 
records in the NDTRS database. 
When all LINK modules are 
live, there will be upwards of 
300,000 separate records held 
across the entire system. 
Case Study 6:  
Speedier, more efficient information for service  
planners, service providers and health policy-makers 
To date, 234 people 
from 96 service 
providers have been 
trained in how to use 
the new NDTRS  
LINK system.
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2016 Objectives: 
• Attract the best people to health research 
by supporting excellent PhD training 
programmes. 
• Provide opportunities for career 
development for postdoctoral researchers 
and emerging investigators. 
• Work with higher education institutions, 
hospital groups and the Health Service 
Executive to identify, develop and support 
leaders in health research. 
• Work with national and international 
partners to facilitate training and exchange 
opportunities that address skills gaps.
Key items delivered in 2016
• Made twenty six awards worth €14.4 million 
under Enabler A.
 >  Of these three awards worth €11.3  
 million were co-funded through the  
 SFI-HRB Wellcome Biomedical Research  
 partnership (HRB contribution of  
 €5.1 million).
• Announced, with Wellcome, €9.1 million in 
joint funding for the Irish Clinical Academic 
Training (ICAT) Programme to support 40 
PhD scholarships over six years.
• Completed interim review of the 
Structured Population and Health-services 
Research Education (SPHeRE) programme 
and initiated planning for Phase II funding. 
• Launched new scheme for Emerging 
Investigator Awards worth €10.5 million 
over five years.
• Awarded 42 Summer Scholarships and one 
Cancer Prevention Fellowship.
• Launched a new joint funding initiative 
with the Fulbright Commission of Ireland 
to encourage health professionals and 
health policy practitioners to avail of travel 
bursaries to relevant US institutions. Four 
awards are expected in 2017.
Enabler A  
 
Support exceptional 
researchers and  
leaders
€14.4m
Made twenty six  
awards worth  
€14.4 million under  
Enabler A.
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The Wellcome–HRB Irish 
Clinical Academic Training 
(ICAT) scheme is the largest all-
island investment in academic 
clinical research. It will train 
eight postgraduate trainee 
doctors per year for a five-
year period, providing fully 
integrated clinical and research 
training up to consultant level.
The Minister for Health, Simon 
Harris T.D., launched the 
scheme at the Wellcome-
HRB Clinical Research Facility 
at St. James’s Hospital. The 
programme will train the 
next generation of doctors in 
research methods. And, as a 
result of HRB investments in 
clinical research infrastructure, 
they will have world-class 
facilities in which to do  
their work.
The award represents a €14.6 
million investment, with €9.1 
million coming from Wellcome 
and the HRB, and an additional 
combined contribution of 
€5.5 million from the Health 
Service Executive, and the 
Health and Social Care 
Research and Development 
Office, Northern Ireland, and 
partner universities. It is one of 
only seven such awards made 
across the UK and Ireland  
by Wellcome. 
Case Study 7:  
Research training for doctors in the health service
The ICAT programme 
will train the next 
generation of doctors 
in research methods.
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Training and career 
development opportunities 
for researchers is a key 
requirement if we are to both 
create and retain the people 
who will be the research 
leaders of the future in our 
healthcare system. 
In 2016, the HRB published 
its Health Research Careers 
Framework and Action Plan. 
This set out how the HRB will 
deliver career training and 
development opportunities 
for researchers at all stages 
in their career journey. These 
include opportunities for:
• early-stage researchers  
through PhD programmes
• mid-stage researchers  
through the development 
of team-based and cross-
disciplinary approaches
• new investigators who 
are ready to transition to 
independence
• leaders in health research.
The Emerging Investigator 
Awards scheme was devised 
expressly to support new 
investigators who are ready to 
transition to independence. 
Over the lifetime of the 
strategy, the scheme will invest 
€15 million to create a cohort 
of new, talented independent 
investigators. It will support 
approximately 10 researchers 
in the first round. There were 
57 eligible applications to 
the first call in 2016, with the 
peer review, interview and 
adjudication process to be 
completed in mid-2017.
Case Study 8:  
Emerging Investigator Awards
Over the lifetime 
of the strategy, the 
scheme will invest 
€15 million to create 
a cohort of new, 
talented independent 
investigators.
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2016 Objectives: 
• Work with the Department of Health and 
key stakeholders to shape the national 
research agenda in relation to health and 
social care. 
• Provide leadership to shape the review, 
conduct and governance of research. 
• Contribute to, and benefit from, 
international developments in policy, 
regulation and legislation relevant to  
health research and healthcare in Ireland. 
• Invest in research infrastructure to 
promote excellence, critical mass, and 
coordination, in order to support HRB 
strategic focus areas and the wider  
health community. 
• Support Irish health researchers to 
participate in Horizon 2020 and other 
European research programmes.
Key items delivered in 2016
• Made four awards, worth €3 million, under 
Enabler B.
• Published Proposals for an Enabling Data 
Environment for Health and Related 
Research in Ireland. This sets out a clear 
roadmap for how Ireland can maximise  
its use of national health data assets  
to improve people’s health and  
healthcare delivery.  
• Invested €2.3 million in the HRB 
Collaboration in Ireland for Clinical 
Effectiveness Reviews (CICER). The 
Health Information and Quality Authority 
successfully secured this award.
• Launched a new Gender and Diversity 
Policy and an Implementation Plan to 
embed gender equality in HRB funding 
programmes and practices. 
• Launched the Public and Patient 
Involvement (PPI) Ignite scheme to fund 
PPI coordinators in Irish universities in 
collaboration with the Irish Research 
Council. Up to five awards will be made  
in 2017.
• Actively promoted the Open Science 
agenda with key activities, which included:   
 > organising a national one-day policy  
 seminar on Open Science in   
 partnership with the ALLEA   
 (All European Academies)   
 e-Humanities Working Group and the  
 Royal Irish Academy (RIA)
 > organising a national one-day   
 information and training   
 seminar on the FAIR (Findable,   
 Accessible, Interoperable, and   
 Re-usable) principles for health  
 researchers
 > securing approval to pilot an Open  
 Science Publishing Platform (F1000)  
 for two years, which will enable  
 researchers to publish their work in  
 a more open manner
 > revising the HRB Open Access policy.
Enabler B  
 
Build a strong  
enabling environment
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• Revised the HRB Evaluation Strategy for 
Funded Research and developed a four-
year implementation plan.
• Assisted Irish health researchers to secure 
€8.9 million from Horizon 2020 for 12 new 
projects, one of which was coordinated  
by an Irish-led team. This was achieved  
with guidance from the HRB National 
Contact Point.
• Supported Irish researcher participation in 
a number of European Joint Programming 
Initiative calls. These included EU Joint 
Programme – Neurodegenerative Disease 
Research, A Healthy Diet for a Healthy Life, 
Antimicrobial Resistance, and More Years, 
Better Lives.
• Organised a review of the Clinical Research 
Facilities Awards and designed a proposal 
for next-phase funding.
• Undertook a scoping exercise for the 
Department of Health to centralise an 
Ethics Service for the conduct of Clinical 
Trials of Investigational Medicinal  
Products (CTIMPs).
• Supported the launch of the Health 
Innovation Hub.
€8.9m
Assisted Irish health 
researchers to secure  
€8.9 million from Horizon 
2020 for 12 new projects.
The HRB launched 
a new Gender and 
Diversity Policy and 
an Implementation 
Plan to embed gender 
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Extracting the most benefit 
from patient and health-
related data, while respecting 
data protection and privacy 
considerations, involves a 
delicate balancing act.  
Ireland has over 100 health 
and health-related databases. 
However, a complex range of 
cultural, social, technical and 
governance issues prevents 
health researchers from 
linking, mining and accessing 
the combined information that 
these databases contain.    
These challenges can lead to 
valuable health research being 
delayed or, in some cases, 
abandoned. In certain cases, 
data have to be collected anew, 
resulting in duplication of effort 
and costs as well as delays in 
securing research results that 
may benefit both people’s 
health and the effective 
delivery of patient care. 
If these data resources could 
be harvested in a safe, secure 
manner, they would have 
tremendous potential to 
advance medical treatments, 
enhance health service 
delivery, and inform policy and 
planning across government 
and civic society.
The HRB Data Project was a 
response to requests from the 
health research community 
to address challenges that 
they experience in relation to 
accessing, sharing and linking 
health-related data. 
The 2016 report Proposals for 
an Enabling Data Environment 
for Health and Related 
Research in Ireland presents 
a model along with proposals 
for the types of infrastructure 
and services required to enable 
safe access, usage and linkage 
of data. The DASSL (Data, 
Access, Storage, Sharing and 
Linkage) model outlines the 
infrastructure and services that 
are required in order to ensure: 
• safe projects  
(valid research purpose)
• safe people 
(trusted researchers)
• safe data and data 
governance  
(people’s data protected)
• safe setting  
(security controls)
• safe outputs  
(disclosure control  
of outputs).
Ireland needs to put in place a 
DASSL-type model if we are to 
unlock the significant value of 
currently underutilised data for 
public benefit. This will require 
the concerted effort of a 
broad range of stakeholders. 
Case Study 9:  
DASSL-ing Ireland and getting the  
most from our health data systems 
Ireland needs to put 
in place a DASSL-type 
model if we are to 
unlock the significant 
value of currently 
underutilised data for 
public benefit.
Proposals for an Enabling Data Environment 
for Health and Related Research in Ireland
Rosalyn Moran
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There is a fundamental 
move across Europe to 
make the research process 
more equitable, inclusive, 
transparent, collaborative  
and efficient. 
Initiatives such as Open 
Science (making research 
more collaborative, 
supporting better quality and 
engagement with society), 
FAIR data principles (making 
data Findable, Accessible, 
Interoperable and Re-usable) 
and gender balance policies 
reflect this EU and global 
ambition. 
During 2016, the HRB played 
a lead role in advancing these 
initiatives in Ireland. Key 
activities included:
• Agreeing to chair the newly 
established National Open 
Research Forum, which has 
a role to play in ensuring 
that Ireland understands 
and promotes open science 
and makes best use of 
our research expertise, 
resources and outputs.
• Hosting a two-day think 
tank about open science 
policies and practices in 
Ireland. Leading figures 
Professor Barend Mons, 
Chair of the High Level 
Expert Group of the 
European Open Science 
Cloud (EOSC), and 
Professor Martin Curley, 
Chair of the EU Open 
Innovation Strategy and 
Policy Group, joined the 
CEOs of the four principal 
Irish research funding 
agencies and other experts 
to lead the discussions. 
The second day of this 
event focused on the 
principles and approaches 
that make research data 
more Findable, Accessible, 
Interoperable and Re-
usable (FAIR).
• Commencing the process 
to run a pilot project for 
an open publishing service. 
This service will enable 
HRB-funded researchers 
to rapidly and openly 
publish a wider array of 
their research findings and 
emerging outputs, with 
minimal barriers. It will 
actively support the HRB 
strategic aim ‘to advance 
the exploitation of data in 
health research to yield 
information that contributes 
to improvements in health’.
• Approving a new gender 
policy to ensure equitable 
and fair treatment of 
both genders in assessing 
applications for funding. 
It will also ensure that the 
design and conduct of 
research considers gender 
influences and issues. The 
new policy applies to all HRB 
funding calls issued from 1 
June 2016. In partnership 
with the Higher Education 
Authority and other Irish 
funding agencies our 
new policy obliges higher 
education institutions 
to have internationally 
recognised gender equality 
accreditation by the end  
of 2019.  
The HRB will actively work 
with the research community, 
government departments, 
funding agencies and higher 
education institutions to 
embed these principles into 
our research processes.
 
Case Study 10:  
Applying sound principles in  
the research process
Professor Barend Mons,  
speaking at the Open Science  
and Ireland meeting.
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2016 Objectives: 
• Ensure a high-performing working 
environment built on innovation, 
adaptability and teamwork.
• Enable transparent and accountable 
decision-making based on the best 
possible information.
• Ensure that HRB systems and processes are 
robust, flexible and scalable.
• Enhance recognition of the values of health 
research and the HRB’s role nationally  
and internationally.
Key items delivered in 2016
• Introduced a Personal and Organisational 
Development programme (POD). 
• Organised a conference for key 
stakeholders to showcase the impact that 
the HRB has had over the past 30 years.
• Reviewed and improved HRB business 
planning and reporting mechanisms to 
better meet the operational needs of the 
Board and the Department of Health and 
to ensure that available resources are 
optimally used. 
• Rebranded the organisation. 
• Continued development of two main 
HRB systems: GEMS, our online Grants 
Electronic Management System, and 
LINK, our common platform for all our 
information systems. 
• The HRB featured in 440 press and  
438 online articles during 2016.  
This equates to €2.7 million in  
advertising value.




The HRB featured in 
440 press and 438 
online articles during 
2016. This equates 




A look back over 30 years  
of growth, success and  
HRB impacts. 
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Our strategy sets out a clear 
plan about what we are 
going to achieve between 
now and 2020. However, it 
does not address how we do 
it, specifically our culture. 
Therefore, the HRB has 
implemented an organisational  
personal development 
programme to help create the 
best possible environment 
within the HRB in order to 
achieve our mission. This 
programme is about building 
on the HRB’s culture and 
embedding the values and 
behaviours that we want to 
have in our organisation. 
The personal and 
organisational development 
programme has two stages. 
The first began in September 
2016 and consisted of an 
internal questionnaire and 
focus groups in which we took 
an honest look at ourselves, 
the values and behaviours we 
see currently and those we 
would like to see. The second 
stage, which will begin in early 
2017, will be to develop an 
action plan designed by staff 
in response to the outcome 
of stage one. We hope this 
will help to create a positive 
work environment, build staff 
morale, enhance management 
and work practices and make 
the HRB a great place to work. 
We see this as an ongoing 
process whereby we grow and 
evolve, both as individuals and 
as a progressive organisation, 
working together in response 
to changing practices, new 
strategies and new staff in 
order to meet our strategic 
objectives and goals. 
Case Study 11:  
Personal and Organisational 
Development Programme
We want to create 
a positive work 
environment.
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The HRB was 30 years old in 
2016. To mark the occasion 
we held a one-day conference 
that demonstrated the power 
of research and evidence to 
improve people’s health and 
enhance health and social  
care delivery. 
The conference was a mix of 
international keynotes and 
HRB-driven success stories. 
This was designed to show 
policy-makers, healthcare 
managers and health 
professionals the positive 
impact of integrating research 
into their normal activities. The 
programme was also designed 
to illustrate how research and 
evidence can extract further 
value from the €14 billion 
health budget.
Over the past 30 years the 
value of health research has 
been consistently recognised
 ‘In the long term, our health 
system will be a reflection of 
the research base  
underpinning it’.
 W.A. Watts, 
 Chairman, HRB, 1986.
 ‘When we invest in health 
research, we invest in the 
future of healthcare and it’s 
important that we don’t lose 
sight of that.’ 
 Dr Reg Shaw,  
Chairman, HRB, 2008.
 ‘Our future health depends 
on innovations in research 
and practical applications of 
new discoveries in policy and 
practice.’ 
 Dr Declan Bedford,  
Chairman, HRB, 2014.
The challenge as we progress is 
to ensure that we close the gap 
between research/evidence 
and policy/practice. That 
message resonated loud and 
clear throughout the event.
Case Study 12:  
HRB 30 conference
This conference was 





positive impact of 
integrating research 
into their normal 
activities.
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The HRB Board comprises 10 members 
appointed by the Minister for Health, as set 
out in Article 5 of the Health Research Board 
(Establishment) Order 1986 (S.I. No 279 of 
1986), as amended. The quorum for meetings 
of the Board is five.
The members of the Board  
during 2016 were:
1.  Dr Declan Bedford (Chair)
3.  Dr Barry Cullen
3.  Professor Michael Joe Duffy
4.  Professor Jane Grimson 
5.  Professor Bernadette Hannigan 
6.  Mr John McCormack
7.  Professor William Molloy 
8.  Professor Charles Normand
9.  Dr Tom O’Callaghan
10.  Dr Marion Rowland
HRB Board and  
Board Committees
Dr Declan Bedford Dr Barry Cullen




Professor William Molloy Professor Charles  
Normand
Dr Tom O’Callaghan Dr Marion Rowland
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The Board has established two committees to 
assist it in carrying out its functions:
Audit Committee
Assists and supports the Board to monitor 
financial reporting, review the effectiveness 
of internal controls, control the internal audit 
function, and communicate with external 
auditors. The Committee met four times 
during 2016. 
Members:
• Mr Tom Lynch (External Chair)
• Dr Declan Bedford
• Dr Barry Cullen
• Professor Michael Joe Duffy
• Professor Jane Grimson
• Dr Tom O’Callaghan
 
Management Development and 
Remuneration Committee
This Committee oversees the procedure for 
the selection of the Chief Executive, reviews 
the remuneration of the Chief Executive 
within the guidelines set from time to time by 
the Government, and acts as a consultative 
group to the Chief Executive to review the 
performance and development of the senior 
management team. The Committee met once 
during 2016.  
Members:
• Dr Declan Bedford (Chair)
• Professor Bernadette Hannigan
• Mr John McCormack
• Professor Charles Normand
• Dr Marion Rowland
HRB Board and  
Board Committees







Dr D Bedford (Chair) 7 (7) 4 (4) 1 (1)
Dr B Cullen 7 (7) 4 (4) –
Professor MJ Duffy 6 (7) 4 (4) –
Professor J Grimson 6 (7) 3 (4) –
Professor B Hannigan 7 (7) – 1 (1)
Mr J McCormack 7 (7) – 1 (1)
Professor W Molloy 6 (7) – –
Professor C Normand 5 (7) – 1 (1)
Dr T O’Callaghan 6 (7) 3 (4) –
Dr M Rowland 6 (7) – 1 (1)
External
Mr Tom Lynch – 2 (4)  –
Attendance at meetings during 2016
(Note: figures in brackets indicate the number of meetings that took place during the year)
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The Health Research Board is an autonomous 
statutory agency set up under the Health 
Research Board (Establishment) Order 1986 (S.I. 
No. 279 of 1986), as amended (the “Acts”). The 
functions of the Health Research Board are to:  
• promote, assist, commission or conduct 
health research to improve health  
and increase the effectiveness of the 
health services
• maintain, develop or support health 
information systems for the purposes of 
research and to provide the evidence for 
health policy and services
• liaise and cooperate with other research 
bodies in the State and outside the State in 
the promotion, commissioning or conduct 
of relevant research
• liaise with other health information bodies 
in the State and, where appropriate, outside 
the State in the development and support of 
health information systems. 
In discharging its functions, the Health 
Research Board is required to have regard to 
such general research and objectives as the 
Minister for Health may, from time to time, 
determine and convey to the Board.
In discharge of its functions in relation to 
health research and information systems,  
the Board shall have regard to excellence  
and relevance to health and best 
international practice.
In addition to its own governing legislation, 
the Health Research Board is also required to 
comply with a range of other statutory (national 
and EU) and administrative requirements. In 
particular, but not limited to, it has put in place 
procedures to ensure compliance with the 
following specific requirements:
Disclosure of interests
In accordance with Article 13 of the Acts, 
members of the Board, members of 
committees and award selection/evaluation 
panels as well as Health Research Board 
staff are required to disclose pecuniary or 
other beneficial interests in, or material to, 
any matter which falls to be considered by 
the Health Research Board, and to exclude 
themselves from the decision-making process.
In accordance with the provisions of the 
Ethics in Public Office Act, 1995 and the 
Standards in Public Office Act, 2001, all 
Health Research Board members and staff 
holding designated positions have provided 
statements of interest, and the Health 
Research Board maintains a Register of Board 
and Committee Members’ Interests.
Freedom of Information Act, 2014
The Health Research Board is a prescribed 
body under the Freedom of Information Act. 
This Act provides a legal right to individuals to 
obtain access to information held by public 
bodies, to the greatest possible extent, 
consistent with the public interest and the right 
to privacy. However, the Act provides strong 
protections for individuals or research teams 
who supply information to the Health Research 
Board that is confidential, commercially 
sensitive or personal. Requests for information 
under this legislation should be addressed to 
the Freedom of Information Officer, Health 
Research Board, Grattan House, 67–72 Lower 
Mount Street, Dublin 2.
Legislation
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Data Protection Acts, 1988 and 2003
The Health Research Board is committed to  
a policy of protecting the rights and privacy  
of individuals in accordance with data 
protection legislation.
Official Languages Act, 2003
The Health Research Board complies with its 
obligations under this Act.
Employment Equality  
Acts 1998 to 2011
The Health Research Board is committed to a 
policy of equal opportunities, and it strives to 
be an employer where individual contributions 
are encouraged and differences are valued. To 
this end, the HRB is committed to ensuring that 
no staff member, or applicant for employment, 
receives less favourable treatment than any 
other on grounds of gender, marital status, 
family status, sexual orientation, religion, age, 
disability, race, membership of the Traveller 
community, or any other grounds that are not 
relevant to good employment practice.
Re-use of Public Sector Information 
Regulations, 2005 
The Health Research Board complies with the 
regulations on the Re-use of Public Sector 
Information (European Communities (Re-Use 
of Public Sector Information) Regulations 2005 
(S.I. No. 279/2005)) and encourages the 
re-use of the information that it produces.
The Safety, Health and Welfare at 
Work Act 2005, as amended
The Health Research Board continues to take 
appropriate measures to protect the safety, 
health and welfare of all employees and 
visitors within its offices in order to meet the 
provisions of this Act, and it has taken steps to 
communicate both the rights and obligations of 
employers and employees under the Act.
Disability Act 2005
The Health Research Board is required to 
comply with the Disability Act, 2005. The Act 
places obligations on public sector employers 
to meet the target of ensuring that at least 
3% of their workforce comprises people with 
disabilities, and that they report on an annual 
basis in relation to the numbers of people 
with disabilities in their employment and the 
measures they are taking to employ people  
with disabilities.
Financial Emergency Measures in  
the Public Interest Acts 2009, 2010, 
2011 and 2013
The Health Research Board is required to 
adhere to the measures set out in the Financial 
Emergency Measures in the Public Interest Acts 
2009, 2010, 2011 and 2013. The Health Research 
Board has implemented all measures required 
by the aforementioned legislation.
Protected Disclosures Act 2014
There were no protected disclosures made to 
the Health Research Board in 2014.
Public procurement
The Health Research Board applies national 
rules and EU public procurement Directives 
to the purchase of goods and services. Where 
practicable, the Health Research Board avails 
of framework agreements put in place by the 
National Procurement Service.
Prompt payment of accounts
The Health Research Board comes under the 
remit of the Prompt Payment of Accounts 
Act, 1997, SI 383/2000 and the European 
Communities (Late Payment in Commercial 
Transactions) Regulations 2012, and it is 
committed to meeting its obligations under 
the 15-day Prompt Payment Rule, which 
came into effect on 2 January 1998. It has 
processes in place to track all invoices, and 
weekly payment runs are carried out, in order 
to ensure prompt payment.  
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Statement of Income and Expenditure  
and Retained Revenue Reserves for the 
Year Ended 31 December 2016
2016 2015
 €  € 
INCOME
Department of Health Revenue Grant (Vote 38 B.1) 31,554,000 30,654,000 
Other Research Funding 1,653,674 1,074,606 
Interest Receivable and Other Income 314 8,348 
Transfer to Capital Reserve of Amount Allocated 




Address major health challenges 10,064,222 9,844,377 
Support healthcare interventions 6,766,214  5,694,930 
Address the research needs of the Irish health 
and social care system
6,749,950 4,809,406 
Support exceptional researchers and leaders 4,739,195 6,522,197
Build a strong enabling environment 2,071,722 2,791,011 
Enhance organisational performance  2,664,790 2,411,804 
33,056,093 32,073,725 
SURPLUS/(DEFICIT) FOR THE YEAR 151,045 (338,720)
Revenue Reserves at 1 January (611,245) (272,525)
REVENUE RESERVES AT 31 DECEMBER (460,200) (611,245)
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Statement of Capital Income and  





Department of Health capital grant (Vote 38 B.1) 10,071,433 10,420,999 
Amortisation of capital reserve account 178,367 182,737 
10,249,800 10,603,736 
EXPENDITURE
Support healthcare interventions 2,236,601 2,044,602 
Address the research needs of the Irish health 
and social care system
1,474,161 1,296,384 
Support exceptional researchers and leaders 5,441,260 5,765,540 
Build a strong enabling environment 887,671 1,066,946 
Enhance organisational performance 22,603 151,845 
Additions to fixed assets 9,137 95,682 
Depreciation 176,867 181,322 
Loss on disposal of fixed assets 1,500 1,415 
10,249,800 10,603,736 
SURPLUS/(DEFICIT) FOR THE YEAR  -  - 
Health Research Board Annual Report 201640
Statement of Financial Position for  
the Year Ended 31 December 2016
2016 2015
  €  € 
FIXED ASSETS
Property, Plant and Equipment 527,181  695,561 
CURRENT ASSETS
Receivables 661,087 365,263 
Investments 641 641 




Amounts falling due within one year:
Payables 1,532,834 1,063,149 
1,532,834 1,063,149
NET CURRENT ASSETS 878,197 371,689
LONG TERM LIABILITIES
Amounts falling due after one year:
Payables 1,338,397 982,934
1,338,397 982,934
TOTAL NET ASSETS 66,981 84,316 
REPRESENTING
Retained Revenue Reserves (460,200) (611,245)
Capital Reserve 527,181 695,561 
  
66,981 84,316
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reconfiguration of disability support services in Ireland. Journal of Intellectual Disabilities, 
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PROJECTS AND PROGRAMMES












capacity in the Maternal 
Health and Maternal 
Morbidity in Ireland 
study: Second baby 
follow-up, intervention 
development and testing, 





ICE Award Prof Cecily Begley €869,272
Role of the TWEAK/Fn14 
pathway in mediating 










Prof Melissa Bowerman €49,976
Patients’ Satisfaction 











Ms Paula Briscoe €10,000









Dr Marion Butler €326,679
Hedgehog control of 







Prof Paul Cahill €318,296
An investigation of the 
role of Staphlococcus 
aureus colonisation of 
healthcare workers in 
nosocomial transmission 
of S. aureus to patients in 









Prof David Coleman €329,445
SAFE: Systematic 
Approach to improving 
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Health Research Board Annual Report 201644














the outcomes of patients 










Ms Orlaith Cormican €13,000
Methadone substitution 








Dr Grainne Cousins €308,345
Development of a multi-
faceted approach to 
reducing and mitigating 










Prof Sam Cromie €279,983
Application of Next 
Generation Sequencing 
for the Genetic 












Prof G Jane Farrar €299,973
Integrative genomic, 
epigenetic and functional 













and Chemometrics to 
accelerate and improve 








Dr Aoife Gowen €326,356
MicroRNAs in the 
mechanism of ketogenic 
diet therapies and as 











Prof David Henshall €144,313
Peer-to-peer 
motivational interview 
intervention for smoking, 
alcohol and physical 
activity among at-risk 
adolescents in low-SES 
communities:  










Prof David Hevey €284,376
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therapies to overcome 
immune impairment in 











Prof Joseph Keane €100,000
Wave 5/6 of The Irish 





TILDA Award Prof Rose Anne Kenny €10,000,000
Translational analysis of 

























Prof Elena Levtchenko €199,999
AVERT: Autoimmunity 
Relapse Prediction Using 











Prof Mark Little €199,394
Pioneering Advances 
for Control of Myopia 











Prof James Loughman €300,000
Ketamine for Relapse 
Prevention in Recurrent 
Depressive Disorder: a 
randomised, controlled 
























Dr Rachel McLoughlin €1,577,507
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mechanism of action of a 
novel histone deacetylase 









Dr Triona Ní 
Chonghaile
€127,136
Identifying the Aetiology 
of Diabetic Progenitor 












Prof Timothy O’Brien €224,957
Reducing resistance to 
beta-lactam antibiotics: 









Prof James O’Gara €328,853
Comparative mass 
spectrometric profiling 
of the dystrophin 
complexome in normal 
versus pathological 
muscles with differing 













Prof Kay Ohlendieck €50,000










Dr Niamh O’Sullivan €129,896
Modelling of 
pharmacokinetics into 
ischemic heart tissue 










Dr Ellen Roche €98,161












Dr Minnie Sarwal €300,000
Pain registration in 











Ms Noeleen Sheridan €7,000
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Supporting prescribing in 
Irish primary care: a non-
randomised pilot study 











Prof Susan Smith €259,443
To determine how the 
National Comprehensive 
Cancer Network (NCCN) 
Guidelines for Tamoxifen 
and Aromatase Inhibitors 
(AIs) can be adapted to 
address the symptom 
burden for women 
with breast cancer in 
the follow-up phase 
of treatment, who are 
receiving care in the 









Ms Elizabeth Summersby €8,525











Dr Mark Tangney €125,950













Dr Ladislav Timulak €323,309
Building a risk calculator 








Prof William Watson €317,080
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Perspectives of partners 
of women who experience 








Ms Jill Atkinson €255,324










Prof John Boland €1,100,000
The ExACT Trial -  
The effectiveness of 
Exercise combined 
with Acceptance and 
Commitment Therapy 
compared to a standalone 
supervised exercise 
intervention for chronic 








Ms Maire-Brid Casey €241,892
SDHB and its role 
in opigenetic 









Dr Ruth Casey €258,489
The Irish kidney gene 
project-identification and 
characterisation of novel 








Dr Dervla Connaughton €256,493
Anti-inflammatory 
therapy for preventing 
stroke and other vascular 
events after ischaemic 








Ms Sara Coveney €91,152
Hybrid repair versus 
conventional open repair 









Ms Ala Elhelali €54,436









Ms Elaine Finucane €54,436










Prof William Gallagher €1,100,000
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Perspectives of partners 
of women who experience 








Ms Jill Atkinson €255,324










Prof John Boland €1,100,000
The ExACT Trial -  
The effectiveness of 
Exercise combined 
with Acceptance and 
Commitment Therapy 
compared to a standalone 
supervised exercise 
intervention for chronic 








Ms Maire-Brid Casey €241,892
SDHB and its role 
in opigenetic 









Dr Ruth Casey €258,489
The Irish kidney gene 
project-identification and 
characterisation of novel 








Dr Dervla Connaughton €256,493
Anti-inflammatory 
therapy for preventing 
stroke and other vascular 
events after ischaemic 








Ms Sara Coveney €91,152
Hybrid repair versus 
conventional open repair 









Ms Ala Elhelali €54,436









Ms Elaine Finucane €54,436










Prof William Gallagher €1,100,000




















Ms Claire Gorry €20,750
Hospital design for 
supporting people with 







Mr Tom Grey €54,235
Artificial Neural Networks, 







Dr Elizabeth Heron €84,798
Use of software and 
computer technology in 
aphasia rehabilitation; 
investigating issues of 







Ms Aine Kearns €162,714
Development and 
validation of metric-
based training to 







Dr Elaine Kehily €251,408
Characterisation of 
polyclonal IgG and 
paraprotein glycosylation 
in multiple myeloma to 
investigate structural and 











making for children and 








Ms Helen Malone €71,990
Risk prediction models 








Ms Sarah McGarrigle €62,498
Interventions for 
improving medication 









Ms Lisa Mellon €32,669
Interventions for 
supporting pregnant 







Ms Maeve O’Connell €66,478
Health Research Board Annual Report 201650











Unwrapping the layers 
of complexity of clinical 
performance assessment 
of physiotherapy students 
and identifying key 
stakeholders’ preferences 
















Prof Luke O’Neill €2,242,603




and outcomes for women 
- the MAMMI study 







Ms Sunita Panda €255,779
Identifying Interventions 






















Dr Susan Spillane €164,000
Towards personalised 
therapy in stricturing 
Crohn’s disease - 
exploring and exploiting 








Dr Emily Stenke €259,104
Sound-based Observation 






Dr Andriy Temko €134,435
Oral hygiene programmes 









Ms Catherine Waldron €3,970
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INFRASTRUCTURE AND NETWORKS











AIIHPC Palliative Care 









Ms Paddie Blaney €210,000
Malnutrition in the 
Elderly Joint Action Call
Department 
of Agriculture, 
Food and the 
Marine
JPI Healthy Diet 
for a Healthy Life
Dr James Conway €249,864
Evaluation of the Pilot 
Implementation of the 
Framework for Safe 





for Safe Nurse 
Staffing and  
Skill-Mix
Prof Johathan Drennan €177,256
Supplemental funding 
for the professional 
development of 
research nurses through 
support of the 10th 
annual conference 
of the Irish Research 
Nurses Network and 
travel bursaries for 
conferences and 
training courses, and 








Prof Joseph Eustace €30,000
Wellcome/Health 








Prof Michael Gill €9,112,528
ICORG General Central 




ICORG Prof Bryan Hennessy €8,995,200
Award for the Irish 








IPPOSI Dr Derick Mitchell €337,500
HRB Collaboration 







HRB-CICER Dr Mairin Ryan €2,248,440









Mr Philip Watts €50,000
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HRB Co-funded awards
Scheme Co-funding partner Co-fund allocation (€) Total award (€)
All Ireland Institute  
of Hospice and 
Palliative Care





St. Vincent’s  
University Hospital
€39,962 €239,491












Collaborative in  







Co-funding partners  





























and Science  
Foundation Ireland
€430,820 €574,426
Grand Total €17,591,141 €24,669,255
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